SEED Biosciences
SEED Biosciences SA is a Swiss EPFL spinoff that builds impedance-based single-cell and 3D dispensing instruments (DispenCell-S4, Dispen3D), disposable consumables, and AI-driven clonality software for biopharma cell line development and organoid research.
- Company typePrivate
- Founded2018
- HeadquartersRenens, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What SEED Biosciences does
SEED Biosciences SA is a Swiss privately held life sciences tools company founded in 2018 as a spinoff from EPFL (Swiss Federal Institute of Technology), headquartered in Epalinges, Vaud. The company builds impedance-based single-cell and 3D biological entity detection and dispensing instruments, anchored on two core platforms: DispenCell-S4 for automated single-cell cloning in cell line development and Dispen3D for spheroid, organoid, and tumoroid seeding. Supporting the hardware are DispenKit, a line of fully disposable sensing consumables offered in research-grade and GMP-ready configurations with Certificates of Analysis, and DispenCell Analyzer, AI-driven clonality verification software available as either an annual multi-platform subscription or a one-time activation license delivered pre-installed on a mini-computer for GMP environments. IQ/OQ qualification services and preventive maintenance plans round out the offering for regulated deployments.
The commercial model combines capital equipment sales (DispenCell-S4 and Dispen3D) with recurring revenue from DispenKit consumables tied to an installed base of 150+ systems across 20 countries, plus subscription and perpetual-license software revenue. SEED goes to market through direct sales in EMEA, USA, and APAC supplemented by a channel partner network, including BPES (Bioprocess Equipment Specialists) for the UK. Customer concentration sits primarily in biopharmaceutical companies engaged in cell line development and cell therapy manufacturing (Novo Nordisk, GSK, Sanofi, Roche, Merck Biopharma, Siemens Healthineers, Catalent, Mural Oncology, RoslinCT), with secondary adoption among 3D biology and organoid researchers and CDMOs. The company's main differentiators are >98% Day 0 probability of clonality, low-pressure (<0.2 psi) gentle dispensing for sensitive cells including hiPSCs, full GMP audit trail with FDA-ready clonality reports, and disposable tips that eliminate cross-contamination risk.
SEED Biosciences firmographics
Firmographics- Name
- SEED Biosciences
- Legal name
- SEED Biosciences SA
- Website
- https://seedbiosciences.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SEED Biosciences SA is a Swiss EPFL spinoff that builds impedance-based single-cell and 3D dispensing instruments (DispenCell-S4, Dispen3D), disposable consumables, and AI-driven clonality software for biopharma cell line development and organoid research.
- Ownership category
- akta.pro rank
SEED Biosciences industry classification
Industry- Product category
- Lab Automation Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
Keywords
Where SEED Biosciences is headquartered
LocationHeadquarters
- HQ city
- Renens
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
SEED Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Hardware Instruments: DispenCell-S4 (GMP-ready single-cell cloning platform) and Dispen3D (3D cell model dispenser) are sold as capital equipment — automated laboratory instruments priced as one-time capital purchases with optional IQ/OQ qualification services.
- DispenKit Consumables: DispenKit is a recurring consumable product line — fully disposable sensing tips for single-cell and 3D workflows, sold in both research and GMP-ready configurations with lot traceability and Certificates of Analysis. Supports recurring revenue from installed instrument base of 150+ systems.
- IQ/OQ Qualification Services: Installation Qualification (IQ) and Operational Qualification (OQ) services plus preventive maintenance plans offered to ensure regulatory readiness and long-term uptime for installed systems.
- DispenCell Analyzer Software: Clonality analysis software available in two licensing models: (1) Annual multi-platform subscription for teams across Windows/macOS/Linux; (2) One-time activation license delivered pre-installed on a dedicated mini-computer for GMP environments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | DispenCell Analyzer Annual Subscription — multi-platform license for modern workflows |
| One time/ perpetual license | Pay-as-you-go | DispenCell Analyzer One-Time Activation License — pre-installed mini-computer GMP-ready deployment |
| Other | Pay-as-you-go | IQ/OQ & Preventive Maintenance Services |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
SEED Biosciences product offering
Product offeringCore offering
SEED Biosciences designs and sells impedance-based single-cell and 3D biology dispensing instruments (DispenCell-S4, Dispen3D) paired with fully disposable sensing consumables (DispenKit) and AI-driven clonality analysis software (DispenCell Analyzer), offering >98% probability of clonality at Day 0, full GMP audit trails, and FDA-ready reports. The portfolio is targeted at biopharma cell line development, CDMO manufacturing, and 3D biology/organoid research workflows.
Product overview
SEED Biosciences provides a portfolio of precision single-cell and 3D biology solutions centered on two core dispensers (DispenCell-S4 and Dispen3D), supported by the DispenCell Analyzer software for AI-driven clonality verification, DispenKit disposable consumables in research and GMP configurations, and IQ/OQ qualification services. The instruments feature a flexible API enabling integration with robotic platforms, and the entire ecosystem is designed for compliance with GMP standards and regulatory documentation requirements.
Differentiator
Problem solved
Functional benefit
Brands
- DispenCell-S4: GMP-Ready automated single-cell cloning platform for industrial workflows, high throughput, and compliant documentation in regulated environments.
- Dispen3D
- DispenKit
- DispenCell Analyzer
Products and services
- DispenCell-S4 Automated, GMP-ready single-cell cloning instrument for industrial cell line development workflows, providing impedance-based detection with >98% probability of clonality, full audit trail, FDA-ready clonality reports, and integration with robotic platforms via flexible API. Targets biopharma cell line development and GMP-compliant manufacturing environments.
- Dispen3D Benchtop instrument for accurate, gentle, automated seeding of spheroids, organoids, and tumoroids into 96- and 384-well plates using impedance-based detection, supporting reproducible 3D cell model workflows with real-time visualization and setup under 5 minutes. Targeted at academic and industrial 3D biology, organoid, and high-throughput screening applications.
- DispenCell Analyzer AI-driven clonality analysis software that confirms single-cell events from impedance data, tracks colony outgrowth, and generates FDA-ready clonality reports with a full GMP audit trail. Available as an annual multi-platform subscription (Windows, macOS, Linux) for distributed teams or as a one-time activation license pre-installed on a dedicated mini-computer for GMP environments.
- DispenKit Fully disposable single-use sensing consumables (tips) with integrated impedance sensing for single-cell and 3D dispensing workflows, available in research-grade and GMP-ready configurations with Certificates of Analysis, sterility testing, BSE/TSE compliance, and lot-level traceability. Sold as a recurring consumable tied to SEED Biosciences' installed instrument base of 150+ systems.
- IQ/OQ and Preventive Maintenance Services Installation Qualification (IQ), Operational Qualification (OQ), and preventive maintenance services delivered by SEED Biosciences to ensure regulatory readiness, full traceability, and long-term uptime for customers operating DispenCell-S4, Dispen3D, and DispenKit in GMP-compliant environments.
Quantifiable outcome
- >98% probability of clonality (above typical FDA thresholds)
- +8 more outcomes
Companies that use SEED Biosciences
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles4 records
SEED Biosciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
SEED Biosciences partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- LiveDropminorJoint workflow combining LiveDrop's microfluidic mini-spheroid production with Dispen3D's impedance-based single-spheroid dispensing for fast, gentle, and reproducible 3D screening assays. Application note titled 'Standardized Manufacturing and Single-Spheroid Dispensing for HTP Testing.'
- Mural OncologycoreMural Oncology (Waltham, USA) collaborated on an application note demonstrating DispenCell's robust performance in cell line development, achieving 98.4% probability of clonality in CHO cells and enabling Day 0 single-cell selection via impedance-based analysis.
- Merck BiopharmacoreMerck Biopharma (Corsier-sur-Vevey, Switzerland) collaborated with SEED Biosciences on an industrial validation of DispenCell for automated single-cell cloning in cell line development. The application note demonstrates significantly higher outgrowth efficiency vs. limiting dilution and supports integration into regulated and high-throughput CLD environments.
- BPES (Bioprocess Equipment Specialists)coreBPES is SEED Biosciences' UK channel partner/reseller for DispenCell-S4, bringing the technology to UK laboratories. BPES provides local application support and expertise, seamless integration into existing workflows, and faster access to reliable single-cell technologies for UK-based researchers. The partnership was announced publicly on LinkedIn and reinforced at ESACT 2026 in Salzburg.
- RoslinCTcoreRoslinCT is a key customer and reference partner using DispenCell for hiPSC-based manufacturing. RoslinCT's CTO Kevin Bruce provides a testimonial highlighting the immediate proof of clonality and electronic traceability that ensures GMP compliance — essential for their partners.
- Roche Institute of Human Biology (IHB)coreRoche's Institute of Human Biology used Dispen3D in a published preprint for a fully integrated microfluidic platform for high-throughput intestinal organoid generation. Dispen3D was used to gently and precisely transfer individual organoids into 96-well plates, confirming cell-friendly impedance-based technology.
- ESC UNIL (École des sciences criminelles)minorLocal installation of DispenCell-S4 at the UNIL School of Criminal Justice in Lausanne, Switzerland for forensic science applications. Demonstrates local deployment and community engagement.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
SEED Biosciences competitors and assessment
Company assessmentDirect peers
- Sphere Fluidics: Sphere Fluidics provides single-cell analysis and microfluidic dispensing platforms (Cyto-Mine) for cell line development and antibody discovery. Comparable niche specialist serving similar biopharma customers with overlapping single-cell and clonality workflows.
- Namocell: Namocell offers single-cell sorting and dispensing instruments targeting cell line development and cell therapy applications. Comparable product category and customer overlap with SEED Biosciences.
- Cytena (BICO Group): Cytena, now part of BICO, develops single-cell dispensing platforms (e.g., c.sight) using similar gentle-droplet and imaging-based detection. Direct competitor to SEED's DispenCell-S4 in single-cell cloning workflows for cell line development.
Others
- Corning Life Sciences: Corning supplies laboratory consumables and platforms including AggreWell for spheroid formation, with which SEED's Dispen3D integrates. Adjacent ecosystem participant and complementary rather than direct competitor.
Broad incumbents
- Thermo Fisher Scientific: Thermo Fisher offers a broad portfolio of life sciences instruments including flow cytometers, cell sorters, and cell line development tools. Major incumbent and benchmark for enterprise procurement in biopharma.
- BD Biosciences (Becton Dickinson): BD Biosciences is a major provider of cell sorters and flow cytometry instruments used in cell line development and cell therapy manufacturing. Large incumbent competing for the same biopharma tooling budget.
- Beckman Coulter Life Sciences (Danaher): Beckman Coulter, owned by Danaher, supplies flow cytometry and cell sorting instruments plus acquired Labcyte for acoustic dispensing. Broad incumbent competing for CLD and bioprocessing instrument budgets alongside SEED's DispenCell-S4.
- Molecular Devices (Danaher): Molecular Devices is a Danaher-owned life sciences instrument platform with cell line development imaging and workflow tools. Co-developed application notes with SEED (iPSC workflows) but competes broadly in CLD and imaging-based clonality verification.
- Sony Biotechnology: Sony Biotechnology provides high-end cell sorters (e.g., SH800, MA900) widely used in cell line development. Broad incumbent in cell sorting workflows that compete for the same customer budgets as SEED's dispensers.
Emerging players
- Berkeley Lights (PhenomeX): Berkeley Lights (now PhenomeX) developed the Beacon single-cell functional screening platform with optofluidic dispensing. Competes with SEED in single-cell workflows for cell line development and cell therapy, though with a different technology approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
SEED Biosciences social profiles
Digital presenceSEED Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
SEED Biosciences leadership team
Management profileNumber of profiles
Profiles6 records
SEED Biosciences funding detail
Funding detailFunding overview
Funding rounds7 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SEED Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SEED Biosciences
What does SEED Biosciences do?
SEED Biosciences designs and sells impedance-based single-cell and 3D biology dispensing instruments (DispenCell-S4, Dispen3D) paired with fully disposable sensing consumables (DispenKit) and AI-driven clonality analysis software (DispenCell Analyzer), offering >98% probability of clonality at Day 0, full GMP audit trails, and FDA-ready reports. The portfolio is targeted at biopharma cell line development, CDMO manufacturing, and 3D biology/organoid research workflows.
Is SEED Biosciences a public or private company?
SEED Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SEED Biosciences founded?
SEED Biosciences was founded in 2018. It employs 11 to 50 people.
Where is SEED Biosciences based?
SEED Biosciences is headquartered in Renens, Switzerland, in the Europe region.
How does SEED Biosciences make money?
Four revenue lines are on record. Hardware Instruments are the primary driver. The others are dispenKit Consumables, IQ/OQ Qualification Services and dispenCell Analyzer Software.
Who are SEED Biosciences's main competitors?
Direct peers on record are Sphere Fluidics, Namocell and Cytena (BICO Group). Corning Life Sciences is listed as an others. Broad incumbents are Thermo Fisher Scientific, BD Biosciences (Becton Dickinson), Beckman Coulter Life Sciences (Danaher), Molecular Devices (Danaher) and Sony Biotechnology. Berkeley Lights (PhenomeX) is listed as an emerging player.
Does SEED Biosciences have an API?
Yes. The DispenCell-S4 and Dispen3D instruments feature a flexible API and modular design that enables integration with robotic platforms and automated workcells. The API supports high-throughput handling of hundreds of clones while maintaining consistent seeding quality and complete audit trails.
What industry is SEED Biosciences in?
SEED Biosciences's product category is Lab Automation Instruments. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 334516 and its SIC code is 3826.